Advertisement
Screener

AUXILIUM PHARMACEUTICALS INC Operating Income

AUXILIUM PHARMACEUTICALS INC Operating Income

AUXILIUM PHARMACEUTICALS INC reported Operating Income of -$23.20 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-10-30.

Discontinued › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2014-10-30

  • AUXILIUM PHARMACEUTICALS INC operating income (loss) for the quarter ending 2014-09-30 was -$23.20M.
  • AUXILIUM PHARMACEUTICALS INC operating income (loss) for the quarter ending 2014-06-30 was -$27.16M.
  • AUXILIUM PHARMACEUTICALS INC operating income (loss) for the quarter ending 2014-03-31 was -$46.06M.
  • AUXILIUM PHARMACEUTICALS INC operating income (loss) for the quarter ending 2013-12-31 was -$14.84M, a 116.39% decline year-over-year.
  • AUXILIUM PHARMACEUTICALS INC operating income (loss) for fiscal 2013 was -$68.08M, a 179.65% decline from fiscal 2012.
  • AUXILIUM PHARMACEUTICALS INC operating income (loss) for fiscal 2012 was $85.48M.
  • AUXILIUM PHARMACEUTICALS INC operating income (loss) for fiscal 2011 was -$33.18M.
  • AUXILIUM PHARMACEUTICALS INC operating income (loss) for fiscal 2010 was -$50.98M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 month
2014-09-30-$23.20M
10-Q · filed 2014-10-30
-$50.35M
derived: sum of 2 quarters · filed 2014-10-30
-$96.42M
10-Q · filed 2014-10-30
-$111.25M
derived: sum of 4 quarters · filed 2014-10-30
2014-06-30-$27.16M
10-Q · filed 2014-08-07
-$73.22M
10-Q · filed 2014-08-07
-$88.05M
derived: sum of 3 quarters · filed 2014-08-07
-$107.85M
derived: sum of 4 quarters · filed 2014-10-30
2014-03-31-$46.06M
10-Q · filed 2014-05-05
-$60.90M
derived: sum of 2 quarters · filed 2014-05-05
-$80.69M
derived: sum of 3 quarters · filed 2014-10-30
-$109.06M
derived: sum of 4 quarters · filed 2014-10-30
2013-12-31-$14.84M
10-K · filed 2014-02-28
-$34.63M
derived: sum of 2 quarters · filed 2014-10-30
-$63.00M
derived: sum of 3 quarters · filed 2014-10-30
-$68.08M
10-K · filed 2014-02-28
2013-09-30-$19.79M
10-Q · filed 2014-10-30
-$48.16M
derived: sum of 2 quarters · filed 2014-10-30
-$53.25M
10-Q · filed 2014-10-30
$37.26M
derived: sum of 4 quarters · filed 2014-10-30
2013-06-30-$28.37M
10-Q · filed 2014-08-07
-$33.45M
10-Q · filed 2014-08-07
$57.05M
derived: sum of 3 quarters · filed 2014-08-07
$46.31M
derived: sum of 4 quarters · filed 2014-08-07
2013-03-31-$5.08M
10-Q · filed 2014-05-05
$85.42M
derived: sum of 2 quarters · filed 2014-05-05
$74.68M
derived: sum of 3 quarters · filed 2014-05-05
$82.28M
derived: sum of 4 quarters · filed 2014-05-05
2012-12-31$90.51M
10-K · filed 2014-02-28
$79.77M
derived: sum of 2 quarters · filed 2014-02-28
$87.36M
derived: sum of 3 quarters · filed 2014-02-28
$85.48M
10-K · filed 2014-02-28
2012-09-30-$10.74M
10-K · filed 2014-02-28
-$3.15M
derived: sum of 2 quarters · filed 2014-02-28
-$5.08M
10-Q · filed 2013-11-06
-$17.12M
derived: sum of 4 quarters · filed 2014-02-28
2012-06-30$7.60M
10-K · filed 2014-02-28
$5.66M
10-Q · filed 2013-08-01
-$6.38M
derived: sum of 3 quarters · filed 2014-02-28
-$10.60M
derived: sum of 4 quarters · filed 2014-02-28
2012-03-31-$1.94M
10-K · filed 2014-02-28
-$13.98M
derived: sum of 2 quarters · filed 2014-02-28
-$18.20M
derived: sum of 3 quarters · filed 2014-02-28
-$23.32M
derived: sum of 4 quarters · filed 2014-02-28
2011-12-31-$12.04M
10-K · filed 2013-02-26
-$16.26M
derived: sum of 2 quarters · filed 2013-02-26
-$21.39M
derived: sum of 3 quarters · filed 2013-02-26
-$33.18M
10-K · filed 2014-02-28
2011-09-30-$4.22M
10-K · filed 2013-02-26
-$9.34M
derived: sum of 2 quarters · filed 2013-02-26
-$21.14M
10-Q · filed 2012-11-08
-$37.44M
derived: sum of 4 quarters · filed 2013-02-26
2011-06-30-$5.13M
10-K · filed 2013-02-26
-$16.92M
10-Q · filed 2012-07-31
-$33.22M
derived: sum of 3 quarters · filed 2013-02-26
-$45.92M
derived: sum of 4 quarters · filed 2013-02-26
2011-03-31-$11.80M
10-K · filed 2013-02-26
-$28.09M
derived: sum of 2 quarters · filed 2013-02-26
-$40.80M
derived: sum of 3 quarters · filed 2013-02-26
-$54.22M
derived: sum of 4 quarters · filed 2013-02-26
2010-12-31-$16.30M
10-K · filed 2012-02-29
-$29.00M
derived: sum of 2 quarters · filed 2012-02-29
-$42.42M
derived: sum of 3 quarters · filed 2012-02-29
-$50.98M
10-K · filed 2013-02-26
2010-09-30-$12.71M
10-K · filed 2012-02-29
-$26.13M
derived: sum of 2 quarters · filed 2012-02-29
-$34.68M
10-Q · filed 2011-11-09
-$47.15M
derived: sum of 4 quarters · filed 2012-02-29
2010-06-30-$13.42M
10-K · filed 2012-02-29
-$21.97M
10-Q · filed 2011-08-02
-$34.45M
derived: sum of 3 quarters · filed 2012-02-29
-$49.29M
derived: sum of 4 quarters · filed 2012-02-29
2010-03-31-$8.55M
10-K · filed 2012-02-29
-$21.03M
derived: sum of 2 quarters · filed 2012-02-29
-$35.87M
derived: sum of 3 quarters · filed 2012-02-29
-$49.03M
derived: sum of 4 quarters · filed 2012-02-29
2009-12-31-$12.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29
-$27.32M
derived: sum of 2 quarters · filed 2012-02-29
-$40.48M
derived: sum of 3 quarters · filed 2012-02-29
-$53.62M
10-K · filed 2012-02-29
2009-09-30-$14.84M
10-Q · filed 2010-11-08
-$28.00M
derived: sum of 2 quarters · filed 2010-11-08
-$41.14M
10-Q · filed 2010-11-08
2009-06-30-$13.16M
10-Q · filed 2010-08-06
-$26.30M
10-Q · filed 2010-08-06
2008-12-31-$48.09M
10-K · filed 2011-03-01